% | $
Quotes you view appear here for quick access.

CryoLife Inc. Message Board

  • wiz3dfx wiz3dfx Jan 13, 2010 9:11 PM Flag

    This is great news. A great addition

    to CRY product family. The value will be unlocked quickly in complimentary offerings. The current Medafor executive team appears amateurish and in over their heads--trying to draw their salaries for as long as they can and doing their shareholders a huge disservice.

    If they were smart, they would buy Cryolife shares with their severance and ride this thing to $15+/share.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • dlhild Jan 13, 2010 10:18 PM Flag

      I own shares of both companies. In my view Medafor management is doing just fine. They have grown sales at 60% a year for the past 3 years. The next 3 years look great too. On the other hand, what was CRY's sales growth rate over this period...perhaps 10% a year...? Think about what this metric does over time. Now ask yourself which company is better managed.

    • dlhild Jan 13, 2010 9:49 PM Flag

      $2/share is not likely to buy many more Medafor shares. The 1.6 million shares purchased were probably founder shares with a basis of a nickel. Most Medafor shareholders own their stock at $2/share. If this deal happens, CRY will have to "pony up". My guess is Medafor is not for sale below $6-$8/share. CRY will have trouble buying Medafor, because CRY stock is cheap...because of CRY's slow sales growth. CRY is unlikely to force Medafor to the table either, because Medafor is now profitable enough to fight CRY to a stand still. SGA, if you want to buy Medafor, get reasonable with your offer, because. Your $2/share offer isn't even in the ball park. If Medafor was part of CRY, CRY's revenue multiplier would probably double overnight. SO CRY shareholders, don't get too excited. The information CRY is putting out is only a small part of the real story.

11.55-0.39(-3.27%)Jun 24 4:03 PMEDT